Researchers found that Sfrp5 expression in oxLDL-treated human vascular smooth muscle cells (HVSMCs) was downregulated. Sfrp5 overexpression inhibited the viability of HVSMCs induced by oxLDL.
[Bioscience, Biotechnology, and Biochemistry]
Home Newsletters Muscle Cell News Sfrp5 Overexpression Reverses oxLDL-Induced Lipid Accumulation in HVSMCs
